Please use this identifier to cite or link to this item:
|Title:||Epidural anesthesia with intravenous dexmedetomidine sedation in the successful anesthetic management of MRI-guided focused ultrasound ablation of early prostatic cancer|
|Keywords:||Alpha 2-adrenergic agonist|
Focused ultrasound ablation
|Source:||Ng, A.T.L., Ip-Yam, P.C. (2011). Epidural anesthesia with intravenous dexmedetomidine sedation in the successful anesthetic management of MRI-guided focused ultrasound ablation of early prostatic cancer. Journal of Anesthesia 25 (5) : 756-759. ScholarBank@NUS Repository. https://doi.org/10.1007/s00540-011-1189-1|
|Abstract:||We report on five patients who underwent MRI-guided focused ultrasound ablation of prostatic cancer under epidural anesthesia with intravenous dexmedetomidine sedation. This pioneering procedure requires an immobile therapeutic field with adequate sedation and analgesia provided to the patients. Duration of the procedure is longer compared to diagnostic MRI scans. In combination with epidural anesthesia, dexmedetomidine was used to provide moderate levels of sedation without causing respiratory depression or hemodynamic instability, and was useful in preventing shivering. The pharmacological properties of dexmedetomidine contribute to make this technique safe and effective. © 2011 Japanese Society of Anesthesiologists.|
|Source Title:||Journal of Anesthesia|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
WEB OF SCIENCETM
checked on Mar 14, 2018
checked on Mar 11, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.